why choose us

Clinical Trials Search

Showing 3,270 of 131,434 result(s)
Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

Status: COMPLETED

Condition: Atopic Dermatitis

Interventions: ATI-2138 Oral Tablets BID

Date: 2024-09-03

Hard and Soft Tissue Changes Following Vestibular Socket Preservation Versus Ice Cream Cone Technique for Management of Defective Fresh Extraction Sockets

Status: COMPLETED

Condition: Socket Shield

Interventions: Subperiosteal tunnel will be created from the facial aspect of the socket orifice and extending apically until the extent of the vestibular access inc

Date: 2024-09-03

Capabilities ofArtificial Intelligence Models in Externation Decision of Patient Who Followed in Intensive Care Unit ()

Status: COMPLETED

Condition: Artificial Intelegence

Interventions: decision-making process regarding patient discharge from the Intensive Care Unit (ICU)

Date: 2024-09-03

ICF-Based Evaluation of the Upper Extremity in Children With Quadriparetic Cerebral Palsy

Status: COMPLETED

Condition: Upper Extremity Spasticity

Interventions: Within the framework of ICF, the Modified Ashworth Scale, the Manual Ability Classification System and the Functional Independence Measure for Childre

Date: 2024-09-03

Pancreatic Surgery and Risk Factors

Status: COMPLETED

Condition: Pancreatic Surgey

Interventions: patients who did pancreas-related surgery

Date: 2024-09-02

Artificial Intelligence and Scoliosis

Status: COMPLETED

Condition: Scoliosis Patients

Interventions:

Date: 2024-09-02

Chronic Neck Pain: Mobility, Sleep, Function

Status: COMPLETED

Condition: Pain

Interventions: The Neck Disability Index (NDI) is the most widely used self-report tool to assess neck pain status, and provides information not only about pain expe

Date: 2024-09-02

THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA

Status: COMPLETED

Condition: Bronchopulmonary Dysplasia

Interventions:

nebulized azithromycin (Xithrone, Amoun, Egypt) that will be initiated from day 7 of birth in a dose of 20 mg;kg;day in two divided doses

Date: 2024-09-02

SUBJECTIVE REFRACTION WITH LIGHTFIELD TECHNOLOGY

Status: COMPLETED

Condition: Refractive Error Correction

Interventions:

Date: 2024-09-02

A Mass Balance Study of TS-172 in Healthy Adult Subjects

Status: COMPLETED

Condition: Healthy Male Subjects

Interventions: Subjects will receive single dose of about 30 mg of TS-172 containing 1 MBq [14C]TS-172 as an oral solution

Date: 2024-09-02